MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image ATEM CAPITAL
ATEM CAPITAL

ATEM CAPITAL

Summary

ATEM Capital invests in innovations across the Life Sciences industry with promise to cure once-incurable diseases that help people live longer.

Deals Overview

Total Deals2
Valued Deals2
Total Value£ 134 M
Avg. Deal Size£ 67 M

Market Context

Sort

16 Sep 2021|France|Biotechnology
Amolyt Pharma
Sectoral Asset Management

Target: AMOLYT PHARMA

Bidder: SECTORAL ASSET MANAGEMENT

6 Service Providers

3 Target | 3 Bidder

7 Dealmakers

4 Target | 3 Bidder

£ 57 M

Value

17 Mar 2022|United States|Health Care Facilities
Triumvira Immunologics
Atem Capital

Target: TRIUMVIRA IMMUNOLOGICS

Bidder: ATEM CAPITAL

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 76 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite